Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma

Curr Oncol. 2022 Sep 7;29(9):6400-6418. doi: 10.3390/curroncol29090504.

Abstract

Retroperitoneal tumors are extremely rare. More than 70% of primary retroperitoneal soft tissue tumors are malignant. The most common sarcomas in the retroperitoneum include liposarcomas and leiomyosarcoma, however other sarcomas, along with benign mesenchymal tumors, can occur. Sarcomas are a heterogenous group of tumors with overlapping microscopic features, posing a diagnostic challenge for the pathologist. Correct tumor classification has become important for prognostication and the evolving targeted therapies for sarcoma subtypes. In this review, the pathology of retroperitoneal soft tissue sarcomas is discussed, which is important to the surgical oncologist. In addition, less common sarcomas and benign mesenchymal tumors of the retroperitoneum, which may mimic sarcoma clinically and pathologically, are also discussed.

Keywords: GIST; leiomyosarcoma; liposarcoma; malignant peripheral nerve sheath tumor; molecular; pathology; retroperitoneum; sarcoma; solitary fibrous tumor.

Publication types

  • Review

MeSH terms

  • Humans
  • Leiomyosarcoma* / pathology
  • Liposarcoma* / pathology
  • Retroperitoneal Neoplasms* / pathology
  • Sarcoma* / pathology
  • Soft Tissue Neoplasms*

Grants and funding

This research received no external funding.